Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):795–802. doi: 10.1111/j.1365-2125.1989.tb03442.x

Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.

J H Jonkman 1, K G Nicholson 1, P R Farrow 1, M Eckert 1, G Grasmeijer 1, B Oosterhuis 1, O E De Noord 1, T W Guentert 1
PMCID: PMC1379807  PMID: 2757895

Abstract

1. The influence of alpha-interferon (Roferon-A) on the pharmacokinetics and metabolism of theophylline was studied in healthy adults. Roferon-A was administered as an intra-muscular injection (3 x 10(6) iu) once-a-day over 3 days. One week prior to and immediately after this course a single 20 min aminophylline infusion (4 mg kg-1) was given. 2. Blood samples for theophylline analysis were taken over 48 h. Urine was collected up to 72 h and assayed for theophylline and its major metabolites 3-methylxanthine, 1,3-dimethyluric acid and 1-methyluric acid. 3. Pharmacokinetic parameters for theophylline in plasma were calculated. From urinary excretion data the overall metabolic clearance of theophylline and clearances for formation of the metabolites were calculated. 4. After interferon administration, there was a significant increase of approximately 15% in the mean values of the terminal elimination half-life, area under the curve and mean residence time of theophylline in association with a similar decrease in plasma clearance (P less than 0.05). Formation clearances of the metabolites tended to be smaller after treatment, but only the change in the overall clearance of theophylline was significantly different (P less than 0.05). There was no systematic shift in the metabolic pattern of theophylline. 5. Additional investigations of the influence of the duration of alpha-interferon treatment are necessary before definite conclusions can be drawn about the mechanism and the clinical relevance of the described interaction.

Full text

PDF
795

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkett D. J., Dahlqvist R., Miners J. O., Lelo A., Billing B. Comparison of theophylline and theobromine metabolism in man. Drug Metab Dispos. 1985 Nov-Dec;13(6):725–728. [PubMed] [Google Scholar]
  2. CORNISH H. H., CHRISTMAN A. A. A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem. 1957 Sep;228(1):315–323. [PubMed] [Google Scholar]
  3. Chang K. C., Bell T. D., Lauer B. A., Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet. 1978 May 27;1(8074):1132–1133. doi: 10.1016/S0140-6736(78)90305-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clark C. J., Boyd G. Theophylline pharmacokinetics during respiratory viral infection. Lancet. 1979 Mar 3;1(8114):492–492. doi: 10.1016/s0140-6736(79)90844-4. [DOI] [PubMed] [Google Scholar]
  5. Danhof M., Breimer D. D. Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. Br J Clin Pharmacol. 1979 Dec;8(6):529–537. doi: 10.1111/j.1365-2125.1979.tb01040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grygiel J. J., Wing L. M., Farkas J., Birkett D. J. Effects of allopurinol on theophylline metabolism and clearance. Clin Pharmacol Ther. 1979 Nov;26(5):660–667. doi: 10.1002/cpt1979265660. [DOI] [PubMed] [Google Scholar]
  7. Hendeles L., Weinberger M. Theophylline. A "state of the art" review. Pharmacotherapy. 1983 Jan-Feb;3(1):2–44. doi: 10.1002/j.1875-9114.1983.tb04531.x. [DOI] [PubMed] [Google Scholar]
  8. Jenne J. W., Nagasawa H. T., Thompson R. D. Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther. 1976 Mar;19(3):375–381. doi: 10.1002/cpt1976193375. [DOI] [PubMed] [Google Scholar]
  9. Jenne J. W. Theophylline: a remarkable window to the hepatic microsomal oxidases. Chest. 1982 May;81(5):529–530. doi: 10.1378/chest.81.5.529. [DOI] [PubMed] [Google Scholar]
  10. Jonkman J. H., Tang D., Upton R. A., Riegelman S. Measurement of excretion characteristics of theophylline and its major metabolites. Eur J Clin Pharmacol. 1981;20(6):435–441. doi: 10.1007/BF00542096. [DOI] [PubMed] [Google Scholar]
  11. Jonkman J. H. Therapeutic consequences of drug interactions with theophylline pharmacokinetics. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):736–742. doi: 10.1016/0091-6749(86)90054-0. [DOI] [PubMed] [Google Scholar]
  12. Jonkman J. H., Upton R. A. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet. 1984 Jul-Aug;9(4):309–334. doi: 10.2165/00003088-198409040-00002. [DOI] [PubMed] [Google Scholar]
  13. Jonkman J. H., Wymenga A. S., de Zeeuw R. A., van der Boon W. V., Beugelink J. K., Oosterhuis B., Jedema J. N. No effect of influenza vaccination on theophylline pharmacokinetics as studied by ultraviolet spectrophotometry, HPLC, and EMIT assay methods. Ther Drug Monit. 1988;10(3):345–348. doi: 10.1097/00007691-198803000-00019. [DOI] [PubMed] [Google Scholar]
  14. Koren G., Greenwald M. Decreased theophylline clearance causing toxicity in children during viral epidemics. J Asthma. 1985;22(2):75–79. doi: 10.3109/02770908509079891. [DOI] [PubMed] [Google Scholar]
  15. Kraemer M. J., Furukawa C. T., Koup J. R., Shapiro G. G., Pierson W. E., Bierman C. W. Altered theophylline clearance during an influenza B outbreak. Pediatrics. 1982 Apr;69(4):476–480. [PubMed] [Google Scholar]
  16. Lohmann S. M., Miech R. P. Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther. 1976 Jan;196(1):213–225. [PubMed] [Google Scholar]
  17. Mannering G. J., Renton K. W., el Azhary R., Deloria L. B. Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems. Ann N Y Acad Sci. 1980;350:314–331. doi: 10.1111/j.1749-6632.1980.tb20631.x. [DOI] [PubMed] [Google Scholar]
  18. Milavetz G., Vaughan L. M., Weinberger M. M. Stability of theophylline elimination rate. Clin Pharmacol Ther. 1987 Apr;41(4):388–391. doi: 10.1038/clpt.1987.46. [DOI] [PubMed] [Google Scholar]
  19. Muir K. T., Jonkman J. H., Tang D. S., Kunitani M., Riegelman S. Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr. 1980 Nov 14;221(1):85–95. doi: 10.1016/s0378-4347(00)81010-5. [DOI] [PubMed] [Google Scholar]
  20. Riegelman S., Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm. 1980 Oct;8(5):509–534. doi: 10.1007/BF01059549. [DOI] [PubMed] [Google Scholar]
  21. Tang-Liu D. D., Williams R. L., Riegelman S. Nonlinear theophylline elimination. Clin Pharmacol Ther. 1982 Mar;31(3):358–369. doi: 10.1038/clpt.1982.46. [DOI] [PubMed] [Google Scholar]
  22. Taylor G., Marafino B. J., Jr, Moore J. A., Gurley V., Blaschke T. F. Interferon reduces hepatic drug metabolism in vivo in mice. Drug Metab Dispos. 1985 Jul-Aug;13(4):459–463. [PubMed] [Google Scholar]
  23. Teunissen M. W., De Leede L. G., Boeijinga J. K., Breimer D. D. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state. J Pharmacol Exp Ther. 1985 Jun;233(3):770–775. [PubMed] [Google Scholar]
  24. Teunissen M. W., Joeres R. P., Vermeulen N. P., Breimer D. D. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo. Xenobiotica. 1983 Apr;13(4):223–231. doi: 10.3109/00498258309052258. [DOI] [PubMed] [Google Scholar]
  25. Theophylline toxicity and viral infections. Pediatrics. 1982 Sep;70(3):508–509. [PubMed] [Google Scholar]
  26. Wagner J. G. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications. Clin Pharmacokinet. 1985 Sep-Oct;10(5):432–442. doi: 10.2165/00003088-198510050-00005. [DOI] [PubMed] [Google Scholar]
  27. Williams S. J., Baird-Lambert J. A., Farrell G. C. Inhibition of theophylline metabolism by interferon. Lancet. 1987 Oct 24;2(8565):939–941. doi: 10.1016/s0140-6736(87)91422-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES